These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meeting. Karussis D; Vaknin-Dembinsky A Expert Rev Clin Immunol; 2010 May; 6(3):347-52. PubMed ID: 20441420 [TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for severe autoimmune diseases: progress and problems. Marmont AM Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258 [TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures. Karussis D; Slavin S J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562 [TBL] [Abstract][Full Text] [Related]
12. Aggressive multiple sclerosis-is there a role for stem cell transplantation? Havrdova E J Neurol; 2005 Sep; 252 Suppl 3():iii34-iii37. PubMed ID: 16170499 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. La Nasa G; Littera R; Cocco E; Battistini L; Marrosu MG; Contu L Ann Hematol; 2004 Jun; 83(6):403-5. PubMed ID: 14648027 [TBL] [Abstract][Full Text] [Related]
14. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group. Comi G; Kappos L; Clanet M; Ebers G; Fassas A; Fazekas F; Filippi M; Hartung HP; Hertenstein B; Karussis D; Martino G; Tyndall A; van der Meché FG J Neurol; 2000 May; 247(5):376-82. PubMed ID: 10896270 [TBL] [Abstract][Full Text] [Related]
15. Suppressing immunity in advancing MS: too much too late, or too late for much? Freedman MS; Atkins HL Neurology; 2004 Jan; 62(2):168-9. PubMed ID: 14745045 [No Abstract] [Full Text] [Related]
16. Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation. Berard JA; Bowman M; Atkins HL; Freedman MS; Walker LA J Neurol Sci; 2014 Jan; 336(1-2):132-7. PubMed ID: 24189209 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis. Kyrcz-Krzemień S; Helbig G; Torba K; Koclęga A; Krawczyk-Kuliś M Hematology; 2016 Jan; 21(1):42-5. PubMed ID: 26330136 [TBL] [Abstract][Full Text] [Related]
18. High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis. Fassas A; Kazis A J Hematother Stem Cell Res; 2003 Dec; 12(6):701-11. PubMed ID: 14977479 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease. Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives. Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]